ArticleBrain and behavior2026
A Diagnosis Model of Typhoon-Related Post-Traumatic Stress Disorder Based on Fixel-Based Analysis in Machine Learning.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPost-traumatic stress disorder (PTSD) is the most common mental disorder following traumatic experiences. Environmental disasters such as super typhoons can severely disrupt daily life and may trigger PTSD in exposed individuals. White matter alterations have been observed in patients with PTSD. Fixel-based analysis (FBA), a recently developed diffusion MRI technique, allows detailed assessment of white matter microstructure. This study aimed to evaluate the potential of FBA as an imaging biomarker in typhoon survivors, reducing the subjective bias associated with clinical symptom scales.
methodsWhole-brain diffusion MRI data from the PTSD group (n = 27), trauma-exposed controls (TEC, n = 33), and healthy controls (HC, n = 30) were analyzed to identify white matter fiber tracts showing abnormalities in FBA metrics, including fiber density (FD), fiber cross-section (FC), and fiber density-cross section (FDC). The study then examined whether these FBA-derived features, when combined with machine learning, could improve the identification of potential PTSD biomarkers.
resultsCompared with the HC group, patients with PTSD showed increased fiber density (FD) in the right frontopontine tract and right middle longitudinal fascicle, as well as higher fiber density-cross section (FDC) values in the bilateral frontopontine tract and left thalamo-premotor tract (Bonferroni correction, p < 0.05/18 = 0.003). To differentiate PTSD from TEC, binary and multiclass machine learning models with five-fold cross-validation were developed. The binary model (PTSD vs. TEC) achieved high performance (accuracy = 0.89, sensitivity = 0.97, specificity = 0.71, precision = 0.87, AUC = 0.95), whereas the multiclass model (PTSD vs. TEC vs. HC) demonstrated excellent results (macro-averaged precision = 0.99, recall = 0.99, F1-score = 0.99). The top 20 contributing features of the optimal model were analyzed using Shapley additive explanation (SHAP) values to illustrate model interpretability.
conclusionMost typhoon-exposed individuals with PTSD may exhibit structural alterations in brain white matter. By combining fixel-based analysis (FBA) with machine learning, this study identified diffusion markers within specific white matter tracts and demonstrated their potential diagnostic value for distinguishing PTSD from trauma-exposed controls. These findings enhance our understanding of microstructural white matter changes and their spatial distribution in PTSD and also suggest potential imaging biomarkers for its diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.